Grant: Cat. Gr.: STBBI Res.: Beyond HIV/AIDS/Hep. C- STBBI other than HIV/hep. C (gen.)
McGill University
$99,529.00
Promoting Equitable Access to Hepatitis B Screening and Treatment in Canada: An Evidence Synthesis Study Using an Integrated Knowledge Translation Approach
FY 2024-25
Summary
Hepatitis B is a pressing public health concern globally and in Canada. Despite effective vaccines and treatments, many individuals, especially within vulnerable populations, do not receive the necessary care due to various barriers. Recognizing these challenges, the World Health Organization and Canada have set ambitious targets to eliminate hepatitis B by 2030. This project, conducted in partnership with public health stakeholders and people living with hepatitis B, aims to develop a robust framework to improve hepatitis B care, particularly for key populations in Canada that face increased risks due to factors like migration status, economic instability, and social exclusion. These populations include immigrants from countries where hepatitis B is common, people who inject drugs, and individuals engaged in high-risk sexual behaviors. The study includes three integrated phases. First, we will conduct a systematic review to assess the effectiveness of current hepatitis B interventions aimed at improving testing, linking infected individuals to care, and initiating and maintaining treatment. Second, we will conduct a systematic review of the literature to identify the barriers that prevent effective hepatitis B care, as well as the factors that facilitate it, from the perspective of managers, healthcare providers and patients. The third phase involves analyzing which interventions are effective, for whom, why, and under what circumstances, incorporating findings from the literature and insights from expert review panels. This comprehensive approach ensures that the strategies proposed are specifically tailored to effectively address the real-world complexities of living with, and managing, hepatitis B. Ultimately, this project aims to inform policy and practice, contributing to the national and global efforts to eliminate hepatitis B as a public health threat by providing targeted, evidence-based strategies for improving health outcomes for those at greatest risk.
Department
Program
Cat. Gr.: STBBI Res.: Beyond HIV/AIDS/Hep. C- STBBI other than HIV/hep. C (gen.)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
507602
Name
Fontaine Guillaume
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C (Catalyst)
Projecttitle
Promoting Equitable Access to Hepatitis B Screening and Treatment in Canada: An Evidence Synthesis Study Using an Integrated Knowledge Translation Approach
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$99,529
Cihrequipment2
$0
Programname2
Cat. Gr.: STBBI Res.: Beyond HIV/AIDS/Hep. C- STBBI other than HIV/hep. C (gen.)
Keyworddelim
Health Equity; Hepatitis B Virus Infection; Immigrants And Newcomers; Implementation Science; Linkage To Care; People Who Use Drugs; Testing; Treatment
Abstract
Hepatitis B is a pressing public health concern globally and in Canada. Despite effective vaccines and treatments, many individuals, especially within vulnerable populations, do not receive the necessary care due to various barriers. Recognizing these challenges, the World Health Organization and Canada have set ambitious targets to eliminate hepatitis B by 2030. This project, conducted in partnership with public health stakeholders and people living with hepatitis B, aims to develop a robust framework to improve hepatitis B care, particularly for key populations in Canada that face increased risks due to factors like migration status, economic instability, and social exclusion. These populations include immigrants from countries where hepatitis B is common, people who inject drugs, and individuals engaged in high-risk sexual behaviors. The study includes three integrated phases. First, we will conduct a systematic review to assess the effectiveness of current hepatitis B interventions aimed at improving testing, linking infected individuals to care, and initiating and maintaining treatment. Second, we will conduct a systematic review of the literature to identify the barriers that prevent effective hepatitis B care, as well as the factors that facilitate it, from the perspective of managers, healthcare providers and patients. The third phase involves analyzing which interventions are effective, for whom, why, and under what circumstances, incorporating findings from the literature and insights from expert review panels. This comprehensive approach ensures that the strategies proposed are specifically tailored to effectively address the real-world complexities of living with, and managing, hepatitis B. Ultimately, this project aims to inform policy and practice, contributing to the national and global efforts to eliminate hepatitis B as a public health threat by providing targeted, evidence-based strategies for improving health outcomes for those at greatest risk.
Competitiondate
202405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fontaine, Guillaume; Feld, Jordan J; Greenaway, Christina A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,529~ $0~